IPO registrations (S-1, F-1) · Registrants
NVN Liquidation, Inc.
- SEC CIK
- 1467154 · filings on EDGAR ↗
- Name on the registration
- Novan, Inc.
- Former names
- Novan, Inc. (2009–2023)
- Registration
- Form S-1, first filed 2016-08-24, last 2019-09-05; 2 initial registrations, 2 amendments
- Outcome
- Final prospectus filed 2016-09-22; declared effective 2016-09-20
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- DE
- Business address
- P.O. BOX 64, Pittsboro, NC 27312
- EIN
- 20-4427682
- EDGAR entity type
- operating
- Insiders and CEO pay
- NVN Liquidation, Inc. on the corporate pages
Offering terms
- Proposed price range
- $11.00–$13.00 per share (S-1/A filed 2016-09-20)
- Final price
- $11.00 per share, within the range (424B4 filed 2016-09-22, an initial public offering)
- Shares sold
- 4,100,000
- Gross proceeds
- $45,100,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol NOVN
- Lead underwriters
- Piper Sandler
- Syndicate
- JMP Securities; Wedbush Securities
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Form 5500 plan sponsor: NOVAN, INC. EXACT (EIN (EXACT))
- Form D issuer: Novan, Inc. EXACT (CIK (EXACT))
- SEC filer: Novan, Inc. EXACT (CIK (EXACT))
Filings 9
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2016-08-24 | S-1 | S-1 (registration) | Novan, Inc. | 0001193125-16-689866 ↗ |
| 2016-09-08 | S-1/A | S-1/A (amendment) | Novan, Inc. | 0001193125-16-705260 ↗ |
| 2016-09-20 | S-1/A | S-1/A (amendment) | Novan, Inc. | 0001193125-16-713804 ↗ |
| 2016-09-20 | EFFECT | EFFECT (declared effective) | Novan, Inc. | 9999999995-16-005733 ↗ |
| 2016-09-22 | 424B4 | 424B4 (final prospectus) | Novan, Inc. | 0001193125-16-717193 ↗ |
| 2017-10-10 | EFFECT | EFFECT (declared effective) | Novan, Inc. | 9999999995-17-002632 ↗ |
| 2019-09-05 | S-1 | S-1 (registration) | Novan, Inc. | 0001467154-19-000085 ↗ |
| 2019-09-11 | EFFECT | EFFECT (declared effective) | Novan, Inc. | 9999999995-19-002069 ↗ |
| 2020-04-10 | EFFECT | EFFECT (declared effective) | Novan, Inc. | 9999999995-20-000723 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2016-09-20 | S-1/A | registration statement | $11.00–$13.00 | 3,750,000 | - | Nasdaq NOVN | 3 | primary document; range, shares headline, cover names 3 | document ↗ | |
| 2016-09-22 | 424B4 | final prospectus | $11.00 | 4,100,000 | $45,100,000 | Nasdaq NOVN | 3 | primary document; price sentence, shares headline, proceeds table, cover names 3 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Geer W Kent | Director | 12 | 2016–2023 | ||
| HUNTER F NEAL | TenPercentOwner | 2 | 2016 | ||
| HUNTER JEFF N | Officer | EVP & Chief Business Officer; Interim CFO, EVP & CBO; VP of Technical Operations | 7 | 2016–2018 | |
| INGRAM ROBERT ALEXANDER | Director | 10 | 2016–2020 | ||
| Johnson Brian M. | Officer | Chief Commercial Officer | 3 | 2016–2017 | |
| KEEGAN ROBERT J | Director | 11 | 2016–2023 | ||
| Malin Corp plc | TenPercentOwner | 3 | 2016–2019 | ||
| Malin Life Sciences Holdings Ltd | TenPercentOwner | 3 | 2016–2019 | ||
| Martin G. Kelly | Director; Director,Officer | Chief Executive Officer; Interim Chief ExecutiveOfficer | 9 | 2016–2019 | |
| Murphy Sean | Director | 4 | 2016–2018 | ||
| PALMOUR JOHN W | Director | 16 | 2016–2022 | ||
| PETERSON RICHARD D | Officer | CFO | 1 | 2016 | |
| Rico M. Joyce | Officer | Chief Medical Officer | 2 | 2016 | |
| Stasko Nathan | Director,Officer | President, CEO, Director; President & CSO, Director | 3 | 2016–2018 | |
| T.D.H. One, LLC | TenPercentOwner | 2 | 2016 | ||
| T.D.H. Two, LLC | TenPercentOwner | 2 | 2016 | ||
| Hodges William L | Officer | Interim Chief Financial Office | 4 | 2017 | |
| STAFFORD PAULA B | Director; Director,Officer | President and CEO; President and COO | 11 | 2017–2022 | |
| SANDERS MACHELLE | Director | 11 | 2017–2023 | ||
| Reedy Creek Investments LLC | TenPercentOwner | 1 | 2018 | ||
| Parker Donald R | TenPercentOwner | 1 | 2018 | ||
| GOODNIGHT JAMES H | TenPercentOwner | 1 | 2018 | ||
| James H. Goodnight Management Trust | TenPercentOwner | 1 | 2018 | ||
| Sun Eugene | Director | 4 | 2018–2019 | ||
| NOVAK ANDREW | Officer | Chief Accounting Officer; VP, Accounting and Bus Ops | 8 | 2018–2022 | |
| GAY JOHN M. | Officer | Chief Financial Officer; VP, Finance & Corp. Controller | 9 | 2019–2023 | |
| BIERMAN JAMES L | Director | 9 | 2020–2023 | ||
| Skolsky Steven D | Director | 6 | 2021–2023 | ||
| John A. Donofrio | Officer | EVP, Chief Operating Officer | 3 | 2022–2023 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2015-12-16 | Novan, Inc. | Biotechnology | $32,840,304 | $32,840,304 | 172 | 2 |
| 2014-08-29 | Novan, Inc. | Biotechnology | $50,000,008 | $50,000,008 | 91 | 2 |
| 2014-03-10 | Novan, Inc. | Biotechnology | $3,502,125 | $3,502,125 | 36 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Form 5500 plan sponsor | NOVAN, INC. | EIN (EXACT) | ||
| Form D issuer | Novan, Inc. | Form D private offerings | CIK (EXACT) | |
| SEC filer | Novan, Inc. | SEC filers (EDGAR) | CIK (EXACT) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.